ATE316097T1 - Peptide mit antibakterieller wirkung - Google Patents

Peptide mit antibakterieller wirkung

Info

Publication number
ATE316097T1
ATE316097T1 AT01903165T AT01903165T ATE316097T1 AT E316097 T1 ATE316097 T1 AT E316097T1 AT 01903165 T AT01903165 T AT 01903165T AT 01903165 T AT01903165 T AT 01903165T AT E316097 T1 ATE316097 T1 AT E316097T1
Authority
AT
Austria
Prior art keywords
inhibiting
peptides
antibacterial effects
endotoxemia
tnf
Prior art date
Application number
AT01903165T
Other languages
English (en)
Inventor
Kevin H Mayo
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of ATE316097T1 publication Critical patent/ATE316097T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01903165T 2000-01-20 2001-01-19 Peptide mit antibakterieller wirkung ATE316097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17725500P 2000-01-20 2000-01-20
US21029700P 2000-06-08 2000-06-08

Publications (1)

Publication Number Publication Date
ATE316097T1 true ATE316097T1 (de) 2006-02-15

Family

ID=26873090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01903165T ATE316097T1 (de) 2000-01-20 2001-01-19 Peptide mit antibakterieller wirkung

Country Status (8)

Country Link
US (1) US7144982B2 (de)
EP (1) EP1252181B1 (de)
AT (1) ATE316097T1 (de)
AU (1) AU2001231016A1 (de)
CA (1) CA2397835A1 (de)
DE (1) DE60116733T2 (de)
ES (1) ES2252187T3 (de)
WO (1) WO2001053335A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2255865C (en) * 1996-05-24 2008-10-14 The Regents Of The University Of Minnesota Synthesis of soluble beta-sheet forming peptides
DE60116733T2 (de) 2000-01-20 2006-11-02 Regents Of The University Of Minnesota, Minneapolis Peptide mit antibakterieller wirkung
US7056514B2 (en) 2002-02-20 2006-06-06 Regents Of The University Of Minnesota Partial peptide mimetics and methods
EP1380290A1 (de) 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
CN1711074B (zh) * 2002-11-15 2010-10-06 尼普洛株式会社 脂质体
ES2287687T3 (es) * 2003-01-09 2007-12-16 Genentech, Inc. Purificacion de polipeptidos.
WO2005009457A1 (en) * 2003-05-15 2005-02-03 Sangstat Medical Corporation Rdp58 compositions and methods for inhibiting vascularization of cell populations
EP1689851A2 (de) * 2003-10-17 2006-08-16 Regents Of The University Of Minnesota Modifizierte polypeptide mit therapeutischer aktivität sowie verwendungsverfahren
SI1725580T1 (sl) * 2004-03-17 2009-06-30 Aplagen Gmbh Izosterična transformacija
CA2583092C (en) 2004-10-04 2014-12-30 Regents Of The University Of Minnesota Antiangiogenic calixarene-based peptide mimetics
EP2386861A3 (de) 2005-07-13 2012-07-18 Crossbeta Biosciences B.V. Cross-Beta-Struktur-bindende Verbindungen
US8114832B2 (en) 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
US10611799B2 (en) * 2017-03-03 2020-04-07 National Tsing Hua University Anti-endotoxin polypeptide
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5595887A (en) 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5348942A (en) 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
US5447913A (en) 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5830860A (en) 1994-03-24 1998-11-03 Regents Of The University Of Minnesota Peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
US5786324A (en) * 1994-03-24 1998-07-28 Regents Of The University Of Minnesota Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
US5955577A (en) 1996-06-27 1999-09-21 Regents Of The University Of Minnesota Method for synthesizing a water-soluble β-sheet forming peptide
WO1999017616A1 (en) 1997-10-07 1999-04-15 New England Medical Center Hospitals, Inc. Structure-based rational design of compounds to inhibit papillomavirus infection
JP4037525B2 (ja) 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
DE60116733T2 (de) 2000-01-20 2006-11-02 Regents Of The University Of Minnesota, Minneapolis Peptide mit antibakterieller wirkung

Also Published As

Publication number Publication date
WO2001053335A3 (en) 2001-12-13
WO2001053335A2 (en) 2001-07-26
ES2252187T3 (es) 2006-05-16
EP1252181B1 (de) 2006-01-18
US7144982B2 (en) 2006-12-05
WO2001053335A9 (en) 2002-10-31
CA2397835A1 (en) 2001-07-26
US20020146406A1 (en) 2002-10-10
AU2001231016A1 (en) 2001-07-31
EP1252181A2 (de) 2002-10-30
DE60116733D1 (de) 2006-04-06
DE60116733T2 (de) 2006-11-02

Similar Documents

Publication Publication Date Title
ATE316097T1 (de) Peptide mit antibakterieller wirkung
ATE427116T1 (de) Behandlung von bakteriellen infektionen
ES2160335T3 (es) Polimeros reticulables.
NO973933L (no) Vaskulær endotelvekstfaktor B
ATE421973T1 (de) Inzektizide proteinen von bacillus thuringiensis
WO2004099246A3 (en) Peptides for use in treating obesity
DE60040623D1 (de) Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
HK1045846A1 (zh) 低分子量補體蛋白酶抑制劑
EP2301563A3 (de) HSP20 Peptide
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
DE60022652D1 (de) Zusammensetzung von ethylenkopolymeren mit erhöhter haftung
AU2002351933A1 (en) Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
DE60034879T8 (de) Lantibiotikum
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
AU2001244286A1 (en) Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
AU2003285286A1 (en) Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol)
AU2003239184A8 (en) Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides
WO2001045738A3 (en) Use of heat shock proteins to enhance production of chemokines by a cell
AU4643501A (en) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
DK1897945T3 (da) IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
DE69937998D1 (de) Antiproliferative und antivirale proteine und peptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties